Literature DB >> 3168176

Fibrin is a determinant of neutrophil sequestration in the lung.

J A Cooper1, S K Lo, A B Malik.   

Abstract

We investigated the role of fibrin in the sequestration of neutrophils in lungs challenged with microembolism. Lungs of chronically prepared awake sheep were imaged after infusion of 111In-neutrophils and 131I-fibrinogen. Thrombin (80 units/kg) was administered to induce fibrin sequestration in the lung. One group received tranexamic acid (4 mg/kg i.v.) to inhibit fibrinolysis, and the control group received a saline infusion. Thrombin infusion increased both 131I-fibrinogen and 111In-neutrophils in the lung, but the increases were greater and more prolonged in the fibrinolysis-inhibited group. We examined the adherence of isolated neutrophils to fibrin matrix to investigate how neutrophil-fibrin interactions could mediate neutrophil sequestration. Unstimulated neutrophils showed a 37.5 +/- 3.1% adherence to fibrin in contrast to a 3.9 +/- 0.4% neutrophil adherence to endothelium and a 6.5 +/- 0.5% adherence to agarose. Neutrophil adherence to fibrin increased to 81.7 +/- 6.2% with activation by phorbol myristate acetate (10(-8) M) and was inhibited by a monoclonal antibody directed against the beta-chain of the CD18 leukocyte adhesion glycoprotein. The findings indicate that retention of pulmonary fibrin microthrombi is associated with increased lung uptake of neutrophils. Fibrin serves as a substrate for neutrophil adherence, and this adherence is mediated by expression of the CD18 glycoprotein complex on neutrophils. Fibrin sequestration in the lung may contribute to lung vascular injury by inducing pulmonary neutrophil uptake.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3168176     DOI: 10.1161/01.res.63.4.735

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  9 in total

1.  Feasibility of tissue plasminogen activator formulated for pulmonary delivery.

Authors:  John S Dunn; Rajiv Nayar; Jackie Campos; Brooks M Hybertson; Yue Zhou; Mark Cornell Manning; John E Repine; Kathleen A Stringer
Journal:  Pharm Res       Date:  2005-09-22       Impact factor: 4.200

Review 2.  α2-Antiplasmin: New Insights and Opportunities for Ischemic Stroke.

Authors:  Guy L Reed; Aiilyan K Houng; Satish Singh; Dong Wang
Journal:  Semin Thromb Hemost       Date:  2016-07-29       Impact factor: 4.180

3.  Matrix Metalloproteinase-9 Mediates the Deleterious Effects of α2-Antiplasmin on Blood-Brain Barrier Breakdown and Ischemic Brain Injury in Experimental Stroke.

Authors:  Satish Singh; Aiilyan K Houng; Guy L Reed
Journal:  Neuroscience       Date:  2017-12-30       Impact factor: 3.590

4.  CD11c/CD18 on neutrophils recognizes a domain at the N terminus of the A alpha chain of fibrinogen.

Authors:  J D Loike; B Sodeik; L Cao; S Leucona; J I Weitz; P A Detmers; S D Wright; S C Silverstein
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-01       Impact factor: 11.205

5.  Role of catalytic and lysine-binding sites in plasmin-induced neutrophil adherence to endothelium.

Authors:  S K Lo; T J Ryan; N Gilboa; L Lai; A B Malik
Journal:  J Clin Invest       Date:  1989-09       Impact factor: 14.808

6.  Bone marrow-derived progenitor cells prevent thrombin-induced increase in lung vascular permeability.

Authors:  Yidan D Zhao; Hiroshi Ohkawara; Stephen M Vogel; Asrar B Malik; You-Yang Zhao
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-10-30       Impact factor: 5.464

7.  Bone marrow progenitor cells induce endothelial adherens junction integrity by sphingosine-1-phosphate-mediated Rac1 and Cdc42 signaling.

Authors:  Yidan D Zhao; Hiroshi Ohkawara; Jalees Rehman; Kishore K Wary; Stephen M Vogel; Richard D Minshall; You-Yang Zhao; Asrar B Malik
Journal:  Circ Res       Date:  2009-08-20       Impact factor: 17.367

8.  Fibrin(ogen) mediates acute inflammatory responses to biomaterials.

Authors:  L Tang; J W Eaton
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307

Review 9.  COVID-19 coagulopathy - what should we treat?

Authors:  Pratima Chowdary
Journal:  Exp Physiol       Date:  2022-06-22       Impact factor: 2.858

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.